The Effect of Fluvoxamine and Metformin for Fatigue in Patients With Long COVID

Key Points

• The aim is to assess the effectiveness of fluvoxamine and metformin in reducing fatigue associated with long COVID.
• Assessing patient symptoms pre- and post-treatment with fluvoxamine and metformin
• Utilizing standardized fatigue measurement scales
• Comparing results among participants with long COVID
• Reduction in fatigue levels among patients using fluvoxamine
• Improvement in overall wellbeing noted with metformin usage
• Combination of both medications shows potential for enhanced effects